| 1 |
Loscocco GG, Gesullo F, Capecchi G, et al. One thousand patients with essential thrombocythemia: the florence-CRIMM experience[J]. Blood Cancer J, 2024, 14(1): 10.
|
| 2 |
Alvarez-Larrán A, Sant'Antonio E, Harrison C, et al. Unmet clinical needs in the management of CALR-mutated essential thrombocythaemia: a consensus-based proposal from the European LeukemiaNet[J]. Lancet Haematol, 2021, 8(9): e658-e665.
|
| 3 |
Aydin GS, Aksoy E, Yönal Hindilerden İ, et al. Analysis of CALR-mutated essential thrombocythemia as a distinct disease entity compared with JAK2 V617F-mutated and triple-negative patients[J]. Turk J Med Sci, 2026, 56(2): 497-508.
|
| 4 |
Pérez Encinas MM, Sobas M, Gómez-Casares MT, et al. The risk of thrombosis in essential thrombocythemia is associated with the type of CALR mutation: a multicentre collaborative study[J]. Eur J Haematol, 2021, 106(3): 371-379.
|
| 5 |
Diala FGI, Caleon RL, Mahdavi Fard A, et al. Unilateral roth spots as an initial presentation in essential thrombocythemia[J]. Retin Cases Brief Rep, 2024, 18(6): 745-746.
|
| 6 |
Jiao L, Huang X, Fan C, et al. Clinical characteristics and management of cerebral venous sinus thrombosis in patients with essential thrombocythemia[J]. Neuropsychiatr Dis Treat, 2021, 17: 1195-1206.
|
| 7 |
Yousaf Q, Khan HA, Ata F, et al. Cerebral venous sinus thrombosis as the initial presentation of essential thrombocythemia - a case report and literature review[J]. eNeurologicalSci, 2022, 27: 100398.
|
| 8 |
李扬, 王阳, 师瑞, 等. 急性重症颅内静脉窦血栓患者血管内介入治疗的安全性和有效性[J/OL]. 中华脑血管病杂志(电子版), 2025, 19(5): 388-396.
|
| 9 |
范玉华, 党超, 余剑, 等. 中国脑血管病临床管理指南(第2版)(节选)——第7章 脑静脉血栓形成临床管理[J]. 中国卒中杂志, 2023, 18(9): 1030-1035.
|
| 10 |
Einhäupl K, Stam J, Bousser MG, et al. EFNS guideline on the treatment of cerebral venous and sinus thrombosis in adult patients[J]. Eur J Neurol, 2010, 17(10): 1229-1235.
|
| 11 |
Liu Z, Xiang Y, Xie C, et al. Mechanisms of cerebral venous sinus thrombosis due to essential thrombocythemia: current status and future perspectives[J]. Thromb Res, 2026, 259: 109613.
|
| 12 |
龚小沉, 杨毅, 李肇坤, 等. CALR基因突变引起的原发性血小板增多症致颅内多发静脉窦血栓形成1例[J]. 中国神经精神疾病杂志, 2025, 51(3): 165-168.
|
| 13 |
Tremblay D. Cytoreduction for ET and PV: who, what, when, and how?[J]. Hematology Am Soc Hematol Educ Program, 2023, 2023(1): 660-666.
|
| 14 |
王楠, 邱宝山, 莫大鹏, 等. 免疫炎症反应在脑静脉血栓形成中的作用机制研究进展[J/OL]. 中华脑血管病杂志(电子版), 2023, 17(6): 609-612.
|
| 15 |
Xu Z, Li X, Feng D, et al. Endovascular therapy versus anticoagulation for treatment of cerebral venous sinus thrombosis: a Meta-analysis[J]. Neurologist, 2021, 27(2): 69-73.
|
| 16 |
Izumi-Tamura T, Takano K, Nagao S, et al. Proinflammatory and prothrombotic conditions in JAK2 V617F-positive MPN: a case of Lemierre's syndrome in essential thrombocythemia[J]. Ann Hematol, 2025, 104(4): 2563-2570.
|
| 17 |
Benmalek R, Mechal H, Zahidi H, et al. Combined venous and arterial thrombosis revealing underlying myeloproliferative disorder in a young patient: a case report[J]. J Med Case Rep, 2021, 15(1): 76.
|
| 18 |
Tanashyan MM, Melikyan AL, Kuznetsova PI, et al. Brain MRI-findings in Ph - negative myeloproliferative disorders[J]. Ter Arkh, 2019, 91(7): 29-34.
|
| 19 |
Krzywicka K, Aguiar de Sousa D, Cordonnier C, et al. Decompressive surgery in cerebral venous sinus thrombosis due to vaccine-induced immune thrombotic thrombocytopenia[J]. Eur J Neurol, 2023, 30(5): 1335-1345.
|